Status:
RECRUITING
Study of Selected X-Linked Disorders: Aicardi Syndrome
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
Aicardi Syndrome Foundation
Conditions:
Aicardi Syndrome
Brain Disorders
Eligibility:
All Genders
Brief Summary
Based on our current understanding of Aicardi syndrome, the condition is hypothesized to occur due to a genetic change on the X-chromosome. The research team is investigating Aicardi syndrome to ident...
Detailed Description
Aicardi syndrome is a sporadic X-linked dominant, presumably male-lethal, neurodevelopmental disorder. It was initially characterized by agenesis of the corpus callosum, neuronal migration defects, ey...
Eligibility Criteria
Inclusion
- Features suggestive of Aicardi syndrome (not all features must be present)
- Agenesis of the corpus callosum
- Chorioretinal lacunae
- Seizures (infantile spasms)
Exclusion
- none
Key Trial Info
Start Date :
October 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00697411
Start Date
October 1 2002
End Date
January 1 2030
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor College of Medicine
Houston, Texas, United States, 77030